0001246360-14-001551.txt : 20140303 0001246360-14-001551.hdr.sgml : 20140303 20140303172812 ACCESSION NUMBER: 0001246360-14-001551 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140228 FILED AS OF DATE: 20140303 DATE AS OF CHANGE: 20140303 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDTRONIC INC CENTRAL INDEX KEY: 0000064670 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 410793183 STATE OF INCORPORATION: MN FISCAL YEAR END: 0429 BUSINESS ADDRESS: STREET 1: 710 MEDTRONIC PKWY STREET 2: MS LC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 BUSINESS PHONE: 7635144000 MAIL ADDRESS: STREET 1: 710 MEDTRONIC PKWY CITY: MINNEAPOLIS STATE: MN ZIP: 55432 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AYOTTE NEIL P CENTRAL INDEX KEY: 0001582015 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07707 FILM NUMBER: 14661651 MAIL ADDRESS: STREET 1: 710 MEDTRONIC PKWY STREET 2: MSLC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 4 1 form.xml PRIMARY DOCUMENT X0306 4 2014-02-28 false 0000064670 MEDTRONIC INC MDT 0001582015 AYOTTE NEIL P 710 MEDTRONIC PKWY MS LC300 MINNEAPOLIS MN 55432 false true false false VP Interim Gen Counsel CorpSec Common Stock 875.72 I ESOP Common Stock 2014-02-28 4 M false 3500 50 A 14398.448 D Common Stock 2014-02-28 4 M false 3500 59.6355 D 10898.448 D Common Stock 2014-02-28 4 S false 116 59.544 D 10782.448 D Employee Stock Option (right to buy) 50 2014-02-28 4 M false 3500 0 D 2004-10-21 2014-10-21 Common Stock 3500 0 D This balance increased by 48.183 shares due to exempt transactions such as dividend reinvestment. The price reported in Column 4, footnote 2, is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.631 to $59.645, inclusive. The reporting person undertakes to provide to Medtronic, Inc., any security holder of Medtronic, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this form. Rhonda L. Ingalsbe, Attorney-in-fact 2014-03-03